IQInvest
Sign in

BMY

Bristol-Myers Squibb Company

NYQ · Healthcare

$67.84

$0.56 (+0.83%)up 0.83%

25 August 2026 · delayed 15+ min

C

Quality score76.7 / 100

Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.

Bristol-Myers Squibb Company earns a C on good profit margins (>10%) and strong ROE (>20%) but high debt-to-equity ratio (>2.0) and low Sharpe ratio (0.21). Good investment opportunity with solid fundamentals.

Model stance BUY Suggested position 8.0% · $800.00 IQInvest estimate
Adjusted for Moderate investors, Medium-term investors 8.0% suggested allocation Change these

These change the suggested position size and the stance, not the category scores. Amount is in dollars.

IQ-BMY-20260825engine v1 · 7-category weighted scorecard

What it is worth, depending who you ask.

Today’s price against the year it has had and the targets analysts publish. Every marker is a reported figure, not a projection of ours.

Lowest analyst target

$40.00

52-week low

$42.52

Mean analyst target

$66.21

Today's price

$67.84

52-week high

$68.64

Highest analyst target

$80.00

BMY trades 97% of the way up its 52-week range, between $42.52 and $68.64. The mean analyst target of $66.21 is 2.4% below today's price.

Today’s price 52-week range Analyst price targets

Scored categories

Financial healthGood profit margins (>10%); Strong ROE (>20%); High debt-to-equity ratio (>2.0) 100.023%

Profit margin

18.87%

Net profit per unit of revenue

healthyWhat this means

Of every 100 units of revenue, this much survives as profit.

A comfortable buffer between revenue and costs.

Operating margin

34.42%

Before interest and tax

very highWhat this means

Profit from operations, before interest and tax, per 100 of revenue.

Typical of software and other businesses with little cost per extra sale.

Gross margin

71.66%

After the cost of goods only

highWhat this means

What is left of revenue after only the direct cost of the product.

Little marginal cost per sale, which is what lets software and pharma fund heavy R&D.

Return on equity

46.60%

Profit per unit of shareholder capital

very strongWhat this means

Profit generated per unit of shareholder capital.

Rare when sustained — check whether debt is flattering it, since borrowing shrinks the equity denominator.

Return on assets

10.72%

Profit per unit of assets

strongWhat this means

Profit generated per unit of everything the company owns.

The assets are working hard.

Debt to equity

201.86

Borrowings against equity

heavily gearedWhat this means

Borrowings measured against shareholder capital.

Debt magnifies both good years and bad, and raises the stakes when rates rise.

Current ratio

1.53

Short-term assets over short-term debts

adequateWhat this means

Short-term assets against short-term obligations.

Enough to cover near-term bills.

Quick ratio

1.29

As above, excluding inventory

comfortableWhat this means

Short-term assets excluding inventory, against short-term debts.

Liquid assets exceed short-term obligations.

Revenue growth

5.70%

Year on year

growingWhat this means

Change in revenue against the same period last year.

A healthy expansion rate.

Earnings growth

153.10%

Year on year

very strongWhat this means

Change in earnings against the same period last year.

Check whether it is repeatable or a one-off — a single asset sale can flatter this badly.

Revenue

$24.46B

Trailing twelve months

Free cash flow

$8.11B

Cash left after capital spending

Operating cash flow

$12.78B

Cash from the business itself

Payout ratio

55.29%

Dividends as a share of earnings

highWhat this means

The share of earnings paid out as dividends.

Most of the profit goes out of the door, leaving less to reinvest.

Growth & momentumStrong 1-year return (50.8%); Low Sharpe ratio (0.21) 70.022%

Return, 1 month

6.67%

Return, 3 months

19.27%

Return, 6 months

13.07%

Return, year to date

29.65%

Return, 1 year

50.82%

Return, 3 years

26.19%

Sharpe ratio

0.21

Return earned per unit of risk

modestWhat this means

Return earned per unit of risk taken.

Below 1 is the common case; return did not strongly outpace the volatility.

Win rate

49.44%

Share of days that closed up

about evenWhat this means

The share of trading days that closed higher.

Close to a coin flip, which is the norm — returns come from the size of moves, not their count.

Average daily return

0.03%

Best day

11.44%

Worst day

-8.51%

ValuationAttractive P/E ratio (14.9); High PEG ratio (2.37); High P/B ratio (6.21) 55.018%

P/E ratio

14.94

Price against trailing earnings

moderateWhat this means

You pay 14.94 for every 1 unit of annual earnings.

Roughly the long-run market average band.

Forward P/E

10.34

Price against forecast earnings

lowWhat this means

Price against next year's *forecast* earnings.

The market expects little growth, or doubts the forecast.

PEG ratio

2.37

P/E adjusted for growth

expensive for the growthWhat this means

P/E divided by the growth rate — it asks whether the price is justified by the growth.

Above 2 you pay more per unit of growth than the convention treats as reasonable.

Price to book

6.21

Price against balance-sheet equity

well above bookWhat this means

Price against the accounting value of the company's net assets.

Normal for asset-light businesses, where the value sits in brands and software the balance sheet never records.

Price to sales

2.82

Price against revenue

moderateWhat this means

Price against revenue — usable when a company has no profit yet.

A common range for a profitable, growing business.

EV / EBITDA

9.05

Whole-company value against cash earnings

moderateWhat this means

Whole-company value, debt included, against cash earnings.

A conventional range.

Enterprise value

$171.42B

Market value plus debt, minus cash — the price of the whole business

Shares outstanding

2,042,714,656

Shares the profit is split across

Dividend yield

3.75%

Annual dividend against price

meaningfulWhat this means

Annual dividend as a percentage of the share price.

A substantial part of the total return arrives as income.

TechnicalPrice well above 200-day SMA (strong uptrend); Strong trend (ADX > 25) 100.015%

RSI (14)

65.1

Above 70 overbought, below 30 oversold

neutralWhat this means

A 0–100 momentum gauge over the last 14 sessions.

The middle band, where most trading days sit.

MACD

1.68

Momentum against its own trend

MACD histogram

0.08

Positive is bullish

ADX

44.2

Trend strength; above 25 is a real trend

strongly trendingWhat this means

Trend strength, regardless of direction.

A powerful move — which also means it is further from its average.

20-day average

$65.18

50-day average

$60.84

200-day average

$56.46

Price vs 50-day

11.50%

Price vs 200-day

20.16%

Bollinger upper

$67.92

Bollinger lower

$62.45

Average true range

1.72

Typical daily trading range

Stochastic %K

85.8

Risk4 measured figures 45.012%

Volatility, annualised

24.63%

How far it swings in a year

normalWhat this means

How far the price typically swings over a year.

A typical range for an individual share.

Beta

0.23

Moves against the wider market

steadier than the marketWhat this means

How much the price moves relative to the wider market.

Tends to move less than the index, in both directions.

Maximum drawdown

-47.67%

Worst peak-to-trough fall

significantWhat this means

The worst peak-to-trough fall in the period measured.

A serious decline, though not unusual over a multi-year window.

Risk category

Moderate

The engine's own banding

Analyst viewAnalyst consensus: Buy; Strong analyst coverage (24 analysts) 80.010%

Consensus

Buy

What covering analysts rate it

Analysts covering

24

Mean price target

$66.21

Highest target

$80.00

Lowest target

$40.00

Implied upside

-2.41%

Target against today's price

below the targetWhat this means

How far the mean analyst target sits above today's price.

Analysts' average target is under the current price.

Price against the S&P 500

180 trading days to 2026-08-25

BMY is 34.5% up over the window, against 11.6% up for the S&P 500 — ahead by 22.9 points.
BMY +34.5%S&P 500 +11.6%
Show the numbers
Sampled across the window. Both columns are rebased to 100 on 2025-12-05, so they can be compared directly.
DateCloseBMY rebasedS&P 500 rebased
2025-12-05$50.45100.0100.0
2025-12-29$52.34103.8100.5
2026-01-21$53.34105.7100.1
2026-02-11$58.66116.3101.0
2026-03-05$59.45117.899.4
2026-03-26$58.17115.394.3
2026-04-17$59.50117.9103.7
2026-05-08$55.53110.1107.7
2026-06-01$54.34107.7110.6
2026-06-23$54.91108.9107.2
2026-07-15$58.72116.4110.2
2026-08-05$63.63126.1112.4

How the score was built

Each category is scored 0–100, then multiplied by its weight. The seven contributions sum to the quality score.
CategoryScoreWeightContribution
Financial health100.023%23.0
Growth & momentum70.022%15.4
Valuation55.018%9.9
Technical100.015%15.0
Risk45.012%5.4
Analyst view80.010%8.0
ESG50.00%0.0
Quality score100%76.7

ESG is scored but carries no weight in this grade. Add ?esg=1 to the address to include it — the engine then redistributes weight across the other six, so the whole scorecard changes, not just one row.

Argue with the model

Every other grader hands you a number. This one hands you the model.

Move a slider, press Recalculate, and the grade is rebuilt from the same category scores. Nothing is hidden: the scores are the engine's, only the weighting is yours.

18%
23%
22%
12%
15%
10%
0%

These are IQInvest's own weights, totalling 100%.

Your grade

C

76.7 / 100

Identical to the IQInvest grade.

All 66 metricsOne flat sortable table, for when you want everything at once.
Metric Category Value Source
Analysts coveringAnalyst view24Yahoo Finance
ConsensusAnalyst viewBuyYahoo Finance
Highest targetAnalyst view$80.00Yahoo Finance
Implied upsideAnalyst view-2.41%Yahoo Finance
Lowest targetAnalyst view$40.00Yahoo Finance
Mean price targetAnalyst view$66.21Yahoo Finance
Current ratioFinancial health1.53Yahoo Finance
Debt to equityFinancial health201.86Yahoo Finance
Earnings growthFinancial health153.10%Yahoo Finance
Free cash flowFinancial health$8.11BYahoo Finance
Gross marginFinancial health71.66%Yahoo Finance
Operating cash flowFinancial health$12.78BYahoo Finance
Operating marginFinancial health34.42%Yahoo Finance
Payout ratioFinancial health55.29%Yahoo Finance
Profit marginFinancial health18.87%Yahoo Finance
Quick ratioFinancial health1.29Yahoo Finance
Return on assetsFinancial health10.72%Yahoo Finance
Return on equityFinancial health46.60%Yahoo Finance
RevenueFinancial health$24.46BYahoo Finance
Revenue growthFinancial health5.70%Yahoo Finance
Average daily returnGrowth & momentum0.03%Yahoo Finance
Best dayGrowth & momentum11.44%Yahoo Finance
Return, 1 monthGrowth & momentum6.67%Yahoo Finance
Return, 1 yearGrowth & momentum50.82%Yahoo Finance
Return, 3 monthsGrowth & momentum19.27%Yahoo Finance
Return, 3 yearsGrowth & momentum26.19%Yahoo Finance
Return, 6 monthsGrowth & momentum13.07%Yahoo Finance
Return, year to dateGrowth & momentum29.65%Yahoo Finance
Sharpe ratioGrowth & momentum0.21Yahoo Finance
Win rateGrowth & momentum49.44%Yahoo Finance
Worst dayGrowth & momentum-8.51%Yahoo Finance
52-week highMarket data$68.64Yahoo Finance
52-week lowMarket data$42.52Yahoo Finance
Average volumeMarket data12,364,103Yahoo Finance
Day highMarket data$67.88Yahoo Finance
Day lowMarket data$66.42Yahoo Finance
EmployeesMarket data32,500Yahoo Finance
OpenMarket data$66.42Yahoo Finance
Previous closeMarket data$67.28Yahoo Finance
VolumeMarket data1,281,812Yahoo Finance
BetaRisk0.23Yahoo Finance
Maximum drawdownRisk-47.67%Yahoo Finance
Risk categoryRiskModerateYahoo Finance
Volatility, annualisedRisk24.63%Yahoo Finance
20-day averageTechnical$65.18Yahoo Finance
200-day averageTechnical$56.46Yahoo Finance
50-day averageTechnical$60.84Yahoo Finance
ADXTechnical44.2Yahoo Finance
Average true rangeTechnical1.72Yahoo Finance
Bollinger lowerTechnical$62.45Yahoo Finance
Bollinger upperTechnical$67.92Yahoo Finance
MACDTechnical1.68Yahoo Finance
MACD histogramTechnical0.08Yahoo Finance
Price vs 200-dayTechnical20.16%Yahoo Finance
Price vs 50-dayTechnical11.50%Yahoo Finance
RSI (14)Technical65.1Yahoo Finance
Stochastic %KTechnical85.8Yahoo Finance
Dividend yieldValuation3.75%Yahoo Finance
Enterprise valueValuation$171.42BYahoo Finance
EV / EBITDAValuation9.05Yahoo Finance
Forward P/EValuation10.34Yahoo Finance
P/E ratioValuation14.94Yahoo Finance
PEG ratioValuation2.37Yahoo Finance
Price to bookValuation6.21Yahoo Finance
Price to salesValuation2.82Yahoo Finance
Shares outstandingValuation2,042,714,656Yahoo Finance
Add to portfolio Compare Peers Set a price target

Yahoo Finance via yfinance · delayed 15 minutes or more